X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs MYLAN (US) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   MYLAN
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
MYLAN
Dec-14
ALEMBIC LTD/
MYLAN
5-Yr Chart
Click to enlarge
High Rs724,254-   
Low Rs342,998-   
Sales per share (Unadj.) Rs4.71,456.2-  
Earnings per share (Unadj.) Rs6.1175.4-  
Cash flow per share (Unadj.) Rs6.2282.4-  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.7723.9-  
Shares outstanding (eoy) m267.03378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x11.32.5 452.4%   
Avg P/E ratio x8.720.7 42.0%  
P/CF ratio (eoy) x8.512.8 66.0%  
Price / Book Value ratio x1.35.0 26.0%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1391,371,817 1.0%   
No. of employees `000NA25.0 0.0%   
Total wages/salary Rs m2070-   
Avg. sales/employee Rs ThNM22,039.1-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,655.0-  
INCOME DATA
Net Sales Rs m1,255550,976 0.2%  
Other income Rs m370-3,212 -11.5%   
Total revenues Rs m1,625547,765 0.3%   
Gross profit Rs m111137,030 0.1%  
Depreciation Rs m3840,467 0.1%   
Interest Rs m223,766 0.0%   
Profit before tax Rs m44269,586 0.6%   
Minority Interest Rs m0-285 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m242,926 0.8%   
Profit after tax Rs m1,63066,374 2.5%  
Gross profit margin %8.924.9 35.6%  
Effective tax rate %5.44.2 128.9%   
Net profit margin %129.812.0 1,077.9%  
BALANCE SHEET DATA
Current assets Rs m1,867484,381 0.4%   
Current liabilities Rs m591378,689 0.2%   
Net working cap to sales %101.619.2 529.9%  
Current ratio x3.21.3 246.9%  
Inventory Days Days9478 120.7%  
Debtors Days Days74107 68.6%  
Net fixed assets Rs m1,791127,467 1.4%   
Share capital Rs m53419,484 2.7%   
"Free" reserves Rs m10,3240-   
Net worth Rs m10,858273,890 4.0%   
Long term debt Rs m41409,164 0.0%   
Total assets Rs m11,5911,103,202 1.1%  
Interest coverage x260.93.9 6,641.7%   
Debt to equity ratio x01.5 0.3%  
Sales to assets ratio x0.10.5 21.7%   
Return on assets %14.18.2 172.3%  
Return on equity %15.024.2 61.9%  
Return on capital %15.213.6 111.5%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Net fx Rs m-2440-   
CASH FLOW
From Operations Rs m23672,426 0.3%  
From Investments Rs m-224-57,117 0.4%  
From Financial Activity Rs m-27-19,084 0.1%  
Net Cashflow Rs m-15-3,775 0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.37 Rs / USD

Compare ALEMBIC LTD With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC LTD With: ALEMBIC PHARMA  UNICHEM LAB  STRIDES PHARMA SCIENCE  WYETH LTD  FRESENIUS KABI ONCO.  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views On News

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 15, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS